LEADER 00921nam0-22003011i-450 001 990001732320403321 005 20190529131338.0 035 $a000173232 035 $aFED01000173232 035 $a(Aleph)000173232FED01 035 $a000173232 100 $a20030910d1968----km-y0itay50------ba 101 0 $afre 102 $aCH 105 $ay-------001yy 200 1 $aRésistance à la tétracycline et au chloramphénicol chez Escherichia coli K12$fClaude Françoise Chuit 210 $aGenève$cUniversité de Genève$d1968 215 $a35 p.$d24 cm 610 0 $aMicrobiologia 676 $a576 700 1$aChuit,$bClaude Françoise$0492815 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aLG 912 $a990001732320403321 952 $a60 OP. 78/43$b43298$fFAGBC 959 $aFAGBC 996 $aRésistance à la tétracycline et au chloramphénicol chez Escherichia coli K12$9365047 997 $aUNINA LEADER 01468nam0 22003251i 450 001 UON00017441 005 20231205102001.943 100 $a20020107d1865 |0itac50 ba 101 $alat 102 $aFR 105 $a|||| 1|||| 200 1 $aDecem Sendavestae excerpta$elatine vertit sententiarum explicationem et criticos commentarios adjecit textum archetypi ad Westergaardi, Spiegelii aliorumque lucibrationes$frecensuit Cajetanus Kossowicz 210 $aParisiis$cexcusum in Typographeo Imperiali$d1865 215 $axiii, 280 p.$d21 cm 517 1$3UON00352031$aAVESTA. Yasna 517 1$3UON00352157$aAVESTA. Yast 517 1$3UON00352158$aAVESTA. Vendidad 606 $aZOROASTRISMO$xTESTI AVESTICI$3UONC000949$2FI 606 $aLINGUA AVESTICA$xTESTI$3UONC004802$2FI 620 $aFR$dParis$3UONL002984 686 $aIR III AV$cIRAN ANTICO - FILOLOGIA - AVESTICO$2A 702 1$aKOSSOWICZ$bCajetanus$3UONV007079 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00017441 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI RARI IR III AV 003 $eSI MR 34862 7 003 966 $aLINGUE IRANICHE - ANTICOIRANICO$yLINGUA AVESTICA - TESTI$3UONC005444 966 $aMANOSCRITTI AVESTICI - CATALOGHI$yLINGUA AVESTICA - TESTI$3UONC006305 996 $aDecem Sendavestae excerpta$91195264 997 $aUNIOR LEADER 03207nam 2200709z- 450 001 9910566481903321 005 20220506 035 $a(CKB)5680000000037561 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81081 035 $a(oapen)doab81081 035 $a(EXLCZ)995680000000037561 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aMetal and Metal Oxide Nanoparticles: Design, Characterization, and Biomedical Applications 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (118 p.) 311 08$a3-0365-3169-6 311 08$a3-0365-3168-8 330 $aDeveloping new materials is usually a time-demanding and meticulous process, but at the same time, it is one of the more promising solutions to obtain a cleaner, safer, and smart future. More in detail, referring to nanomaterials, an increasingly successfully tool of nanotechnologies, nanoparticles are categorized as materials in which at least one dimension is less than 100 nm in diameter. Among the various nanoparticles' categories, metal and metal oxides nanoparticles stand as an emerging nanotechnological solution for a wide range of biological and medical physio/pathological open questions. This Special Issue covers the fundamental science, design, characterization, and biomedical applications of metal and metal oxide nanomaterials. The articles here presented will embrace all the aspects determining the performance of these systems, ranging from their synthesis, design, chemical, physical, and biological functionalization, to their characterization and successful applications. 517 $aMetal and Metal Oxide Nanoparticles 606 $aTechnology: general issues$2bicssc 610 $abismuth oxide 610 $achemotherapy 610 $adrug-eluting stent 610 $agold nanoparticles 610 $ahydrogel 610 $aimmobilization 610 $airon oxide nanoparticles 610 $ajanus particles 610 $amagnetic nanoparticles 610 $amagnetite nanoparticles 610 $amesoporous zinc oxide 610 $ametal nanoparticles 610 $an/a 610 $ananoparticles 610 $ananoshells (hollow spheres) 610 $apH-triggered drug release 610 $aphotodynamic therapy 610 $aphotothermal therapy 610 $apickering emulsion 610 $apolyHEMA 610 $apolymer coating 610 $aprotein 610 $aradiopacity 610 $areactive oxygen species 610 $aself-assembly 610 $asilver nanoparticles 610 $asonodynamic therapy 610 $atheragnostic 610 $atitanium dioxide nanoparticles 610 $azinc nanoparticles 615 7$aTechnology: general issues 700 $aLimongi$b Tania$4edt$01326306 702 $aLimongi$b Tania$4oth 906 $aBOOK 912 $a9910566481903321 996 $aMetal and Metal Oxide Nanoparticles: Design, Characterization, and Biomedical Applications$93037288 997 $aUNINA